The TIMI risk score is a widely used bedside tool for stratifying patients with unstable angina or non-ST-elevation myocardial infarction (UA/NSTEMI). It converts 7 pieces of clinical information already gathered at presentation into a single 0-7 number that estimates a patient's 14-day risk of death, MI, or urgent revascularization, helping guide how aggressively to manage the case.

How the TIMI risk score works

Each of the 7 criteria — age 65 or older, 3 or more CAD risk factors, known coronary artery disease, aspirin use in the prior 7 days, severe angina, ST-segment deviation of 0.5mm or more, and elevated cardiac biomarkers — is scored as present (1 point) or absent (0 points), for a total of 0 to 7. The total maps to a published 14-day risk of death, myocardial infarction, or urgent revascularization, ranging from 4.7% at a score of 0-1 up to 40.9% at a score of 6-7. These risk percentages come from the original derivation and validation cohorts reported by Antman et al. (JAMA 2000).

The 7 criteria

Some criteria reflect baseline cardiovascular risk (age, risk factor count, known CAD), while others reflect the acuity of the current presentation (severe angina, ST deviation, elevated biomarkers). The aspirin criterion is somewhat distinct: an event occurring despite recent aspirin use suggests a more treatment-resistant process and was independently associated with worse outcomes in the derivation cohort. Because each criterion contributes equally (1 point), the score is quick to calculate at the bedside without weighting calculations.

Scope and limitations

The TIMI risk score for UA/NSTEMI was derived and validated in patients with unstable angina or non-ST-elevation MI — it is not intended for ST-elevation MI (STEMI), which has its own separate TIMI risk score, or for hemodynamically unstable patients who need immediate protocol activation regardless of score. Like most clinical risk scores, it estimates population-level risk and does not replace an individualized clinical assessment, additional risk-stratification tools, or a treating clinician's judgment about revascularization timing.